# Paediatric psoriasis and biologics: An evidence gap in plain sight

**Authors:** Stephan Traidl, Sascha Gerdes

PMC · DOI: 10.1111/jdv.70309 · 2026-03-25

## Full-text entities

- **Genes:** IL23R (interleukin 23 receptor) [NCBI Gene 149233] {aka PSORS7}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}
- **Diseases:** Psoriasis (MESH:D011565), inflammatory (MESH:D007249), plaque (MESH:D003773), cardiometabolic (MESH:D024821)
- **Chemicals:** bimekizumab (MESH:C000625981), deucravacitinib (MESH:C000628674), risankizumab (MESH:C000601773), guselkumab (MESH:C000588857), tildrakizumab (MESH:C000598434), icotrokinra (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC13014436